Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference

Saturday, September 22, 2007 General News J E 4
LYNDHURST, N.J., Sept. 21 Quest DiagnosticsIncorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,information and services, announced that it is scheduled to speak at the 2007UBS Global Life Sciences Conference in New York City on Monday, September 24,2007. The Quest Diagnostics presentation is scheduled to begin at 4:30 p.m.Eastern Time.

The presentation will be webcast live during the conference and will beavailable to registered investors on the following site: andto the public on In addition, the archived webcastwill be available three hours after conclusion of the live event and willremain available until October 27, 2007.

Quest Diagnostics is the leading provider of diagnostic testing,information and services that patients and doctors need to make betterhealthcare decisions. The company offers the broadest access to diagnostictesting services through its national network of laboratories and patientservice centers, and provides interpretive consultation through its extensivemedical and scientific staff. Quest Diagnostics is a pioneer in developinginnovative new diagnostic tests and advanced healthcare information technologysolutions that help improve patient care. Additional company information isavailable at:

The statements in this press release which are not historical facts orinformation may be forward-looking statements. These forward-lookingstatements involve risks and uncertainties that could cause actual results andoutcomes to be materially different. Certain of these risks and uncertaintiesmay include, but are not limited to, competitive environment, changes ingovernment regulations, changing relationships with customers, payers,suppliers and strategic partners and other factors described in the QuestDiagnostics Incorporated 2006 Form 10-K and subsequent SEC filings.

SOURCE Quest Diagnostics


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The First Incisionless Transoral Fundoplication fo...
Employers to Learn Tactics for Managing Ever-Incre...